Douglas Scott Micalizzi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 7 | 2025 | 949 | 1.910 |
Why?
|
Epithelial-Mesenchymal Transition | 6 | 2022 | 754 | 1.240 |
Why?
|
Neoplasm Metastasis | 8 | 2022 | 4892 | 1.160 |
Why?
|
Blood Chemical Analysis | 1 | 2024 | 434 | 0.780 |
Why?
|
Ribosomal Proteins | 2 | 2020 | 369 | 0.680 |
Why?
|
Transforming Growth Factor beta | 6 | 2021 | 1996 | 0.660 |
Why?
|
Homeodomain Proteins | 8 | 2015 | 2429 | 0.660 |
Why?
|
Breast Neoplasms | 13 | 2023 | 21162 | 0.590 |
Why?
|
Protein Biosynthesis | 1 | 2021 | 2093 | 0.440 |
Why?
|
Neoplastic Stem Cells | 3 | 2017 | 1349 | 0.430 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3610 | 0.380 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2012 | 304 | 0.340 |
Why?
|
Mesoderm | 2 | 2009 | 679 | 0.330 |
Why?
|
Mammary Glands, Human | 2 | 2010 | 201 | 0.330 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3235 | 0.320 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 186 | 0.320 |
Why?
|
Epithelium | 2 | 2009 | 1606 | 0.300 |
Why?
|
Mass Screening | 1 | 2024 | 5454 | 0.290 |
Why?
|
Cell Line, Tumor | 12 | 2022 | 17089 | 0.280 |
Why?
|
Mice, SCID | 4 | 2022 | 2626 | 0.280 |
Why?
|
Mice, Nude | 4 | 2022 | 3618 | 0.250 |
Why?
|
Embryonic Development | 1 | 2010 | 722 | 0.240 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5444 | 0.240 |
Why?
|
Leukapheresis | 1 | 2025 | 150 | 0.230 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2012 | 496 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 2841 | 0.220 |
Why?
|
Neoplasms | 5 | 2025 | 22350 | 0.210 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2012 | 0.210 |
Why?
|
Neoplastic Processes | 1 | 2022 | 36 | 0.210 |
Why?
|
Tristetraprolin | 1 | 2020 | 40 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8623 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 1664 | 0.160 |
Why?
|
Epithelial Cells | 2 | 2010 | 3698 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
Cadherins | 1 | 2022 | 903 | 0.150 |
Why?
|
Mice, Inbred NOD | 3 | 2012 | 1836 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 393 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
Epitopes | 1 | 2022 | 2526 | 0.130 |
Why?
|
Animals | 14 | 2022 | 168939 | 0.130 |
Why?
|
Mice | 10 | 2022 | 81898 | 0.130 |
Why?
|
Lethargy | 1 | 2015 | 43 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 802 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2060 | 0.120 |
Why?
|
Mammary Glands, Animal | 2 | 2020 | 273 | 0.120 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 735 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1155 | 0.110 |
Why?
|
Smad7 Protein | 1 | 2012 | 39 | 0.100 |
Why?
|
Cell Separation | 1 | 2017 | 1718 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2039 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2012 | 125 | 0.100 |
Why?
|
Humans | 24 | 2025 | 766812 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3942 | 0.090 |
Why?
|
Cell Survival | 1 | 2021 | 5749 | 0.090 |
Why?
|
Lymphangiogenesis | 1 | 2012 | 171 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2631 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1660 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 616 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2144 | 0.080 |
Why?
|
Cell Dedifferentiation | 1 | 2010 | 125 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2011 | 457 | 0.080 |
Why?
|
Smad3 Protein | 1 | 2009 | 166 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2662 | 0.080 |
Why?
|
Cell Movement | 1 | 2021 | 5204 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3600 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 326 | 0.080 |
Why?
|
Down-Regulation | 1 | 2015 | 2931 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3915 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5330 | 0.070 |
Why?
|
MicroRNAs | 2 | 2015 | 3789 | 0.070 |
Why?
|
Up-Regulation | 3 | 2012 | 4143 | 0.070 |
Why?
|
Signal Transduction | 6 | 2020 | 23618 | 0.070 |
Why?
|
Headache | 1 | 2015 | 1260 | 0.070 |
Why?
|
Leukemia | 1 | 2015 | 1521 | 0.070 |
Why?
|
Blood Platelets | 1 | 2017 | 2465 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2887 | 0.070 |
Why?
|
Female | 13 | 2025 | 396532 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2952 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 716 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2025 | 11094 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16722 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2010 | 11657 | 0.050 |
Why?
|
Apoptosis | 1 | 2018 | 9514 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2391 | 0.050 |
Why?
|
Aneuploidy | 1 | 2025 | 573 | 0.050 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2020 | 43 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2025 | 3667 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7612 | 0.040 |
Why?
|
Disease Progression | 2 | 2023 | 13642 | 0.040 |
Why?
|
Microfluidics | 1 | 2025 | 650 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2023 | 562 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9101 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5795 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 328 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2020 | 378 | 0.040 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2025 | 789 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 661 | 0.040 |
Why?
|
K562 Cells | 1 | 2020 | 644 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 551 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 397 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 30214 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 694 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5795 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5690 | 0.030 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2015 | 64 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6869 | 0.030 |
Why?
|
Prognosis | 3 | 2012 | 29959 | 0.030 |
Why?
|
Piracetam | 1 | 2015 | 88 | 0.030 |
Why?
|
Nootropic Agents | 1 | 2015 | 159 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27158 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 361 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2025 | 2535 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6105 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2882 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3605 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4114 | 0.020 |
Why?
|
Cell Cycle | 1 | 2020 | 2925 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9528 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3427 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1674 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 736 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1894 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2547 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 545 | 0.020 |
Why?
|
Cyclin A1 | 1 | 2008 | 11 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4349 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1852 | 0.020 |
Why?
|
Cyclin A | 1 | 2008 | 59 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1962 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13489 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2008 | 381 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1536 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 655 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1902 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2721 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10451 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18986 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2901 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4570 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5022 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3796 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6225 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81657 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2829 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22351 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6514 | 0.010 |
Why?
|
Male | 3 | 2025 | 364154 | 0.010 |
Why?
|
DNA Damage | 1 | 2008 | 2469 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11062 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4166 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18329 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20710 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36570 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171344 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 223267 | 0.000 |
Why?
|
Adult | 1 | 2015 | 223305 | 0.000 |
Why?
|